Business Wire

Tishomingo Connect expands fiber network into rural Mississippi with Adtran Mosaic One

5.9.2024 14:00:00 CEST | Business Wire | Press release

Share

News summary: Service provider required scalable fiber access technology to give more underserved customers access to reliable, high-speed internet Adtran’s Mosaic One and 10G fiber access platform enable Tishomingo Connect to scale its network rapidly and efficiently Deployment expands broadband access across rural Mississippi, supporting national efforts to close the digital divide

Adtrantoday announced that Tishomingo Connect, a subsidiary of Tishomingo County Electric Power Association (TCEPA), has deployed its Mosaic One SaaS solution to enhance rural broadband access. Leveraging Adtran’s full suite of fiber-to-the-premises and home networking technologies, Tishomingo Connect is ensuring more households and businesses can benefit from its broadband service. With Adtran’s scalable and programmable fiber access technology, the service provider can maximize its existing network investment as it expands its service area to meet the growing demand for fast and reliable internet in Northeast Mississippi. Adtran’s partner LogicomUSA is also playing a key role in the development and deployment of the new broadband network, providing technical support and ongoing NOC services.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905594150/en/

Adtran’s technology is helping Tishomingo Connect deliver high-speed broadband to underserved regions of rural Mississippi. (Photo: Business Wire)

“Fiber broadband revitalizes communities and transforms lives by increasing economic activity and enabling access to services such as telehealth. That’s why we’re determined to extend the reach of our fiber network to ensure that more households and businesses in rural areas can enjoy the same high-quality broadband as those in other parts of the state,” said Cody Durham, CEO and GM of Tishomingo Connect. “By deploying Adtran’s fiber broadband technology and harnessing the support offered by its expert team, we’re expanding our network rapidly to give communities the connectivity they deserve. What’s more, with Mosaic One, we can deliver a more efficient, consistent and reliable service for all our members.”

Tishomingo Connect’s strategic investment in Adtran’s high-capacity fiber access platform ensures they can leverage extra capacity as data demand rises. With Adtran’s scalable XGS-PON OLTs and SDX Series optical network terminals, offering up to 10Gbit/s symmetrical data rates, network expansion is seamless and rapid. Additionally, Adtran’s SDG 800 Series service delivery gateways deliver high-speed Wi-Fi 6 performance, guaranteeing robust connectivity for an increasing number of household devices. Mosaic One further empowers Tishomingo Connect with actionable intelligence, enhancing subscriber experience and optimizing operations through a comprehensive view of customer interactions. AI-driven insights enable timely maintenance and reduce service disruptions, improving network reliability and cutting operating costs.

“Adtran is proud to be a partner of Tishomingo Connect as it continues its vital work of bringing fiber broadband to its members living in underserved regions of rural Mississippi,” commented John Scherzinger, GM of Americas sales at Adtran. “We have a deep understanding of the challenges and opportunities involved for electric utilities moving into the fiber broadband space. We also have the expertise, experience and technology to ensure these crucially important high-capacity rural networks are built in the most cost-effective way possible. With our Mosaic One and multigigabit fiber access solutions, Tishomingo has a seamless and cost-effective upgrade path to offering even more capable services in the future.”

“We support the work of electric cooperative subsidiaries like Tishomingo Connect to increase broadband connectivity in regions long overlooked by other service providers. That’s why we’re proud to offer a range of value-added services that ensure more rural subscribers can take advantage of a fast and reliable internet connection,” noted Noah Southerland, CEO of LogicomUSA. “Our technology and comprehensive support services are designed to minimize costs and time without compromising quality. This makes it easier for Tishomingo Connect to deploy and manage its broadband network, and it also means end-users benefit from high-quality connectivity they can always rely on.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

Published by 
ADTRAN Holdings, Inc. 
www.adtran.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905594150/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye